共查询到20条相似文献,搜索用时 375 毫秒
1.
Tomomitsu Nasuno Sachiyo Mimaki Makito Okamoto Hiroyasu Esumi Katsuya Tsuchihara 《Cancer science》2014,105(2):202-210
Effective molecular target drugs that improve therapeutic efficacy with fewer adverse effects for esophageal cancer are highly anticipated. Poly(ADP‐ribose) polymerase (PARP) inhibitors have been proposed as low‐toxicity agents to treat double strand break (DSB)‐repair defective tumors. Several findings imply the potential relevance of DSB repair defects in the tumorigenesis of esophageal squamous cell carcinoma (ESCC). We evaluated the effect of a PARP Inhibitor (AZD2281) on the TE‐series ESCC cell lines. Of these eight cell lines, the clonogenic survival of one (TE‐6) was reduced by AZD2281 to the level of DSB repair‐defective Capan‐1 and HCC1937 cells. AZD2281‐induced DNA damage was implied by increases in γ‐H2AX and cell cycle arrest at G2/M phase. The impairment of DSB repair in TE‐6 cells was suggested by a sustained increase in γ‐H2AX levels and the tail moment calculated from a neutral comet assay after X‐ray irradiation. Because the formation of nuclear DSB repair protein foci was impaired in TE‐6 cells, whole‐exome sequencing of these cells was performed to explore the gene mutations that might be responsible. A novel mutation in RNF8, an E3 ligase targeting γ‐H2AX was identified. Consistent with this, polyubiquitination of γ‐H2AX after irradiation was impaired in TE‐6 cells. Thus, AZD2281 induced growth retardation of the DSB repair‐impaired TE‐6 cells. Interestingly, a strong correlation between basal expression levels of γ‐H2AX and sensitivity to AZD2281was observed in the TE‐series cells (R2 = 0.5345). Because the assessment of basal DSB status could serve as a biomarker for selecting PARP inhibitor‐tractable tumors, further investigation is warranted. 相似文献
2.
Ali Mteyrek Elisabeth Filipski Catherine Guettier Malgorzata Oklejewicz Gijsbertus T.J. van der Horst Alper Okyar Francis Lévi 《International journal of cancer. Journal international du cancer》2017,140(11):2473-2483
A coordinated network of molecular circadian clocks in individual cells generates 24‐hr rhythms in liver metabolism and proliferation. Circadian disruption through chronic jet lag or Per2 clock gene mutation was shown to accelerate hepatocarcinoma development in mice. As divergent effects were reported for clock genes Per and Cry regarding xenobiotic toxicity, we questioned the role of Cry1 and Cry2 in liver carcinogenesis. Male WT and Cry1?/?Cry2?/? mice (C57Bl/6 background) were chronically exposed to diethylnitrosamine (DEN) at ZT11. Rest‐activity and body temperature rhythms were monitored using an implanted radiotransmitter. Serum aspartate and alanine aminotransferases (AST and ALT) were determined on four occasions during the progression stage. After 7 months, serum alkaline phosphatases (ALP) were determined, and livers were sampled for microscopic tumor nodule counting and histopathology. Five months after initiation of DEN treatment, we found that Cry1?/?Cry2?/? mice developed severe liver dysplasia, as evident from the increased AST, ALT and ALP levels, as compared to WT mice. DEN exposure induced primary liver cancers in nearly fivefold as many Cry1?/?Cry2?/? mice as compared to WT mice (p = 0.01). Microscopic study revealed no difference in the average number of hepatocarcinomas and a nearly eightfold increase in the average number of cholangiocarcinomas in Cry1?/?Cry2?/? mice, as compared to WT mice. This study validated the hypothesis that molecular circadian clock disruption dramatically increased chemically induced liver carcinogenesis. In addition, the pronounced shift toward cholangiocarcinoma in DEN exposed Cry1?/?Cry2?/? mice revealed a critical role of the Cry clock genes in bile duct carcinogenesis. 相似文献
3.
Colorectal liver metastases with a disrupted circadian rhythm phase shift the peripheral clock in liver and kidney
下载免费PDF全文
![点击此处可从《International journal of cancer. Journal international du cancer》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Sander A. Huisman Malgorzata Oklejewicz Ali R. Ahmadi Filippo Tamanini Jan N.M. Ijzermans Gijsbertus T.J. van der Horst Ron W.F. de Bruin 《International journal of cancer. Journal international du cancer》2015,136(5):1024-1032
4.
目的:研究缺氧诱导因子-3α(HIF-3α)对肝癌细胞生物钟基因表达的影响。方法:将HIF-3α过表达的慢病毒载体感染HepG2细胞,构建稳定过表达HIF-3α肝癌细胞系,同时通过siRNA干扰HepG2细胞中HIF-3α的表达。然后通过Real-time PCR和Western Blot检测HIF-3α感染前后肝癌细胞中生物钟基因Clock、Bmal1、NPAS2、Per1、Per2、Per3、Timeless、Cry1、Cry2、REV-ERBA、Rora、CKIε的表达水平。结果:Real-time PCR结果显示HIF-3α使Per3、CKIε mRNA表达升高(P均<0.05),Bmal1、Per1、Per2、Cry1、REV-ERBA、Rora mRNA表达降低(P均<0.05),HIF-3α对Clock、NPAS2、Timeless、Cry2 mRNA的表达无明显影响(P均>0.05)。Western Blot结果与PCR结果相一致。结论:HIF-3α可引起肝癌细胞生物钟基因的紊乱,可能是肝癌生物钟基因表达异常的原因之一。 相似文献
5.
Zhen Chen Jia Tang Xuefei Cai Yao Huang Qingzhu Gao Li Liang Ling Tian Yi Yang Yaqiu Zheng Yuan Hu Ni Tang 《Cancer science》2016,107(10):1380-1389
HBx mutations (T1753V, A1762T, G1764A, and T1768A) are frequently observed in hepatitis B virus (HBV)‐related hepatocellular carcinoma (HCC). Aberrant activation of the Wnt/β‐catenin signaling pathway is involved in the development of HCC. However, activation of the Wnt/β‐catenin signaling pathway by HBx mutants has not been studied in hepatoma cells or HBV‐associated HCC samples. In this study, we examined the effects of HBx mutants on the migration and proliferation of HCC cells and evaluated the activation of Wnt/β‐catenin signaling in HBx‐transfected HCC cells and HBV‐related HCC tissues. We found that HBx mutants (T, A, TA, and Combo) promoted the migration and proliferation of hepatoma cells. The HBx Combo mutant potentiated TOP‐luc activity and increased nuclear translocation of β‐catenin. Moreover, the HBx Combo mutant increased and stabilized β‐catenin levels through inactivation of glycogen synthase kinase‐3β, resulting in upregulation of downstream target genes such as c‐Myc, CTGF, and WISP2. Enhanced activation of Wnt/β‐catenin was found in HCC tissues with HBx TA and Combo mutations. Knockdown of β‐catenin effectively abrogated cell migration and proliferation stimulated by the HBx TA and Combo mutants. Our results indicate that HBx mutants, especially the Combo mutant, allow constitutive activation of the Wnt signaling pathway and may play a pivotal role in HBV‐associated hepatocarcinogenesis. 相似文献
6.
DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first‐line chemotherapy
下载免费PDF全文
![点击此处可从《International journal of cancer. Journal international du cancer》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Beatrice Casini Francesca Sperati Matteo Pallocca Irene Terrenato Laura Pizzuti Patrizia Vici Domenico Sergi Luigi Di Lauro Carla Azzurra Amoreo Enzo Gallo Maria Grazia Diodoro Edoardo Pescarmona Ilio Vitale Maddalena Barba Simonetta Buglioni Marcella Mottolese Maurizio Fanciulli Ruggero De Maria Marcello Maugeri‐Saccà 《International journal of cancer. Journal international du cancer》2017,140(11):2587-2595
The DNA damage response (DDR) network is exploited by cancer cells to withstand chemotherapy. Gastric cancer (GC) carries deregulation of the DDR and harbors genetic defects that fuel its activation. The ATM‐Chk2 and ATR‐Chk1‐Wee1 axes are deputed to initiate DNA repair. Overactivation of these pathways in cancer cells may represent an adaptive response for compensating genetic defects deregulating G1‐S transition (e.g., TP53) and ATM/ATR‐initiated DNA repair (e.g., ARID1A). We hypothesized that DDR‐linked biomarkers may predict clinical outcomes in GC patients treated with chemotherapy. Immunohistochemical assessment of DDR kinases (pATM, pChk2, pChk1 and pWee1) and DNA damage markers (γ‐H2AX and pRPA32) was performed in biological samples from 110 advanced GC patients treated with first‐line chemotherapy, either in phase II trials or in routine clinical practice. In 90 patients, this characterization was integrated with targeted ultra‐deep sequencing for evaluating the mutational status of TP53 and ARID1A. We recorded a positive association between the investigated biomarkers. The combination of two biomarkers (γ‐H2AXhigh/pATMhigh) was an adverse factor for both progression‐free survival (multivariate Cox: HR 2.23, 95%CI: 1.47–3.40) and overall survival (multivariate Cox: HR: 2.07, 95%CI: 1.20–3.58). The relationship between the γ‐H2AXhigh/pATMhigh model and progression‐free survival was consistent across the different TP53 backgrounds and was maintained in the ARID1A wild‐type setting. Conversely, this association was no longer observed in an ARID1A‐mutated subgroup. The γ‐H2AXhigh/pATMhigh model negatively impacted survival outcomes in GC patients treated with chemotherapy. The mutational status of ARID1A, but apparently not TP53 mutations, affects its predictive significance. 相似文献
7.
An association between clock genes and clock‐controlled cell cycle genes in murine colorectal tumors
Matúš Soták Lenka Polidarová Peter Ergang Alena Sumová Jiří Pácha 《International journal of cancer. Journal international du cancer》2013,132(5):1032-1041
Disruption of circadian machinery appears to be associated with the acceleration of tumor development. To evaluate the function of the circadian clock during neoplastic transformation, the daily profiles of the core clock genes Per1, Per2, Rev‐Erbα and Bmal1, the clock‐controlled gene Dbp and the clock‐controlled cell cycle genes Wee1, c‐Myc and p21 were detected by real‐time RT‐PCR in chemically induced primary colorectal tumors, the surrounding normal tissue and in the liver. The circadian rhythmicity of Per1, Per2, Rev‐Erbα and Dbp was significantly reduced in tumor compared with healthy colon and the rhythmicity of Bmal1 was completely abolished. Interestingly, the circadian expression of Per1, Per2, Rev‐Erbα and Dbp persisted in the colonic tissue surrounding the tumor but the rhythmic expression of Bmal1 was also abolished. Daily profiles of Wee1, c‐Myc and p21 did not exhibit any rhythmicity either in tumors or in the colon of healthy animals. The absence of diurnal rhythmicity of cell cycle genes was partially associated with ageing, because young healthy mice showed rhythmicity in the core clock genes as well as in the Wee1 and p21. In the liver of tumor‐bearing mice the clock gene rhythms were temporally shifted. The data suggest that the circadian regulation is distorted in colonic neoplastic tissue and that the gene‐specific disruption may be also observed in the non‐neoplastic tissues. These findings reinforce the role of peripheral circadian clockwork disruption for carcinogenesis and tumor progression. 相似文献
8.
9.
10.
EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor‐β‐mediated growth inhibition in hepatocellular carcinoma
下载免费PDF全文
![点击此处可从《Cancer science》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Kohichiroh Yasui Chika Konishi Yasuyuki Gen Mio Endo Osamu Dohi Akira Tomie Tomoko Kitaichi Nobuhisa Yamada Naoto Iwai Taichiro Nishikawa Kanji Yamaguchi Michihisa Moriguchi Yoshio Sumida Hironori Mitsuyoshi Shinji Tanaka Shigeki Arii Yoshito Itoh 《Cancer science》2015,106(7):929-937
11.
Yang X Wood PA Oh EY Du-Quiton J Ansell CM Hrushesky WJ 《Breast cancer research and treatment》2009,117(2):423-431
Purpose Per2, a core circadian clock gene, has tumor suppressor properties and is mutated or down regulated in human breast cancers. We
have manipulated the expression of this gene in vitro and in vivo to more fully understand how the Per2 clock gene product affects cancer growth. Methods We used siRNA and shRNA to down regulate Per2 expression in vitro and in vivo and measured cancer cell proliferation, tumor growth rate and several molecular pathways
relevant to cancer growth and their circadian organizations. All statistical tests were two-sided. Results Down regulation of functional Per2 gene expression increases Cyclin D and Cyclin E levels and doubles in vitro breast cancer cell proliferation (P < 0.05). Down regulation of Per2 also accelerates in vivo tumor growth and doubles the daily amplitude of the tumor growth rhythm (P < 0.05). Conclusions The clock gene Per2 exerts its tumor suppressor function in a circadian time dependent manner. Therefore, Per2 and perhaps other clock genes represent a new class of potential therapeutic targets whose manipulation will modulate cancer
growth and cancer cell proliferation. 相似文献
12.
Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway
下载免费PDF全文
![点击此处可从《International journal of cancer. Journal international du cancer》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Qing Xie Linlin Chen Xuefeng Shan Xiaoliang Shan Jia Tang Fan Zhou Qingmei Chen Huiqin Quan Dan Nie Wenlu Zhang Ai‐Long Huang Ni Tang 《International journal of cancer. Journal international du cancer》2014,135(3):635-646
Secreted frizzled‐related proteins (SFRPs) are antagonists of the Wnt signaling pathway whose epigenetic downregulation have been shown to be involved in hepatocarcinogenesis. However, dysregulation of SFRPs induced by hepatitis B virus (HBV) X protein (HBx) has never been studied in HBV‐related hepatocellular carcinoma (HBV‐HCC). In this study, we sought to determine the clinical significance and underlying mechanism of HBx‐induced SFRPs dysregulation in hepatoma cells and HBV‐HCC patients. Our results showed that SFRP1 and SFRP5 expression were dramatically decreased by HBx in hepatoma cells. The repressed expression in hepatoma cells was partially rescued by a DNA methylation inhibitor and synergistically increased by a combination treatment with a histone deacetyltransferases inhibitor. In addition, we identified that SFRP1 and SFRP5 promoters were hypermethylated in both HBx‐expressing hepatoma cells and HBV‐HCC tissues. Downregulation of SFRP1 and SFRP5 in HBV‐HCC tissues was significantly correlated with overexpression of DNA methyltransferase 1 (DNMT1) and poor tumor differentiation. HBx facilitated the binding of DNMT1 and DNMT3A to SFRP1 and SFRP5 promoters, and resulted in epigenetic silencing of SFRP1 and SFRP5. Moreover, overexpression of SFRP1, SFRP5 or RNA interference mediated silencing of DNMT1 inactivated the Wnt signaling pathway and decreased the expression levels of Wnt target genes c‐Myc and CyclinD1, thus impeding HCC growth in vitro and in vivo, and regressing HBx‐induced epithelial–mesenchymal transition (EMT). Our findings strongly suggest that epigenetic silencing of SFRP1 and SFRP5 by HBx allows constitutive activation of Wnt signaling pathway and hence contributes to hepatocarcinogenesis. 相似文献
13.
Amanda K. Smolarek Jae Young So Paul E. Thomas Hong Jin Lee Shiby Paul Anne Dombrowski Chung‐Xiou Wang Constance Lay‐Lay Saw Tin Oo Khor Ah‐Ng Tony Kong Kenneth Reuhl Mao‐Jung Lee Chung S. Yang Nanjoo Suh 《Molecular carcinogenesis》2013,52(7):514-525
Previous clinical and epidemiological studies of vitamin E have used primarily α‐tocopherol for the prevention of cancer. However, γ‐tocopherol has demonstrated greater anti‐inflammatory and anti‐tumor activity than α‐tocopherol in several animal models of cancer. This study assessed the potential chemopreventive activities of a tocopherol mixture containing 58% γ‐tocopherol (γ‐TmT) in an established rodent model of mammary carcinogenesis. Female ACI rats were utilized due to their sensitivity to 17β‐estradiol (E2) to induce mammary hyperplasia and neoplasia. The rats were implanted subcutaneously with sustained release E2 pellets and given dietary 0.3% or 0.5% γ‐TmT for 2 or 10 wk. Serum E2 levels were significantly reduced by the treatment with 0.5% γ‐TmT. Serum levels of inflammatory markers, prostaglandin E2 and 8‐isoprostane, were suppressed by γ‐TmT treatment. Histology of mammary glands showed evidence of epithelial hyperplasia in E2‐treated rats. Immunohistochemical analysis of the mammary glands revealed a decrease in proliferating cell nuclear antigen (PCNA), cyclooxygenase‐2 (COX‐2), and estrogen receptor α (ERα), while there was an increase in cleaved‐caspase 3, peroxisome proliferator‐activated receptor γ (PPARγ), and nuclear factor (erythroid‐derived 2)‐like 2 (Nrf2) in γ‐TmT‐treated rats. In addition, treatment with γ‐TmT resulted in a decrease in the expression of ERα mRNA, whereas mRNA levels of ERβ and PPARγ were increased. In conclusion, γ‐TmT was shown to suppress inflammatory markers, inhibit E2‐induced cell proliferation, and upregulate PPARγ and Nrf2 expression in mammary hyperplasia, suggesting that γ‐TmT may be a promising agent for human breast cancer prevention. © 2012 Wiley Periodicals, Inc. 相似文献
14.
Jing Zhao Yun Wang Ming Han Hongping Lu Xiaofan Chen Shunai Liu Xiaoxue Yuan Kai Han Pu Liang Jun Cheng 《Cancer science》2020,111(3):994-1007
The effect of hepatitis C virus p7 trans‐regulated protein 3 (P7TP3) in the development of hepatocellular carcinoma (HCC) is still unknown. The present study aimed to investigate the role and mechanism of P7TP3 in HCC. P7TP3 was significantly decreased in HCC tissues when compared with corresponding liver tissues immediately around the tumor (LAT) from seven HCC patients. Fewer and smaller colonies originated from HepG2‐P7TP3 cells when compared to HepG2‐NC cells. Overexpression of P7TP3 in HepG2 cells significantly repressed the growth of HCC xenografts in nude mice. Furthermore, wound‐healing tests, Transwell assays, Matrigel Transwell assays, adhesion assays, CCK‐8 assays, flow cytometry and western blotting analysis showed that P7TP3 protein expression inhibited migration, invasion, adhesion, proliferation and cell cycle progression in HCC cell lines. Moreover, P7TP3 suppressed the activity of the Wnt/β‐catenin signaling pathway, and was restored by Wnt3a, which is an activator of the Wnt/β‐catenin signaling pathway. Consistently, β‐catenin was highly expressed by P7TP3 silencing, and restored by XAV939, an inhibitor of the Wnt/β‐catenin signaling pathway. Finally, microRNA (miR)‐182‐5p suppressed the expression of target gene P7TP3 by directly interacting with the 3′‐UTR region. Taken together, P7TP3, the direct target gene of miR‐182‐5p, inhibited HCC by regulating migration, invasion, adhesion, proliferation and cell cycle progression of liver cancer cell through the Wnt/β‐catenin signaling pathway. These findings provide strong evidence that P7TP3 functions as a new promising tumor suppressor in HCC. 相似文献
15.
Heng Xiao Rongliang Tong Chaofeng Ding Zhen Lv Chengli Du Chuanhui Peng Shaobing Cheng Haiyang Xie Lin Zhou Jian Wu Shusen Zheng 《Oncotarget》2015,6(4):2180-2192
Hepatocellular carcinoma (HCC) is one of the most deadly cancers. Using mRNA microarray analysis, we found that H2AX decreased under hypoxic conditions. Hypoxia is an important physiological and pathological stress that induces H2AX phosphorylation (γ-H2AX), but the regulatory mechanism of γ-H2AX remains elusive in the progress of HCC. We report here that increased γ-H2AX expression in HCC is associated with tumor size, vascular invasion, TNM stage and reduced survival rate after liver transplantation (LT). γ-H2AX knockdown was able to effectively inhibit VEGF expression in vitro and tumorigenicity and angiogenesis of HCC in vivo. The mechanism of γ-H2AX on the angiogenic activity of HCC might go through EGFR/HIF-1α/VEGF pathways under hypoxic conditions. Combined γ-H2AX, HIF-1α and EGFR has better prognostic value for HCC after LT. This study suggests that γ-H2AX is associated with angiogenesis of HCC and γ-H2AX or a combination of γ-H2AX/EGFR/HIF-1α is a novel marker in the prognosis of HCC after LT and a potential therapeutic target. 相似文献
16.
Chie Nishioka Takayuki Ikezoe Jing Yang Naoki Komatsu H. Phillip Koeffler Akihito Yokoyama 《International journal of cancer. Journal international du cancer》2009,125(5):1168-1176
We have recently reported that the mitogen‐activated protein kinase/ERK kinase (MEK) inhibitor AZD6244 (ARRY‐142886) strikingly potentiated the effects of histone deacetylase inhibitor to induce growth arrest and apoptosis of acute myelogeneous leukemia (AML) cells in association with enhanced upregulation of p21waf1. This study examined the effects of the MEK inhibitor on the action of DNA methyltransferase inhibitor 5‐Aza‐2′‐deoxycytidine (5‐AzadC), another epigenetic agent in AML cells. AZD6244 significantly potentiated the ability of 5‐AzadC to induce growth arrest and apoptosis of NB4, and freshly isolated AML cells. In parallel, 5‐AzadC induced expression of p21waf1 in AML cells, which was potently enhanced in the presence of AZD6244. Further studies explored the molecular mechanisms by which 5‐AzadC induced expression of p21waf1 and found that a low dose of 5‐AzadC (1 μM) induced acetylation of histone H3 on the p21waf1 gene promoter; however, higher dose of this compound (3 or 5 μM) potently induced DNA damage as assessed by expression of γH2AX, in NB4 cells. These effects were strikingly enhanced by concomitant blockade of MEK signaling. Furthermore, knock‐down of p21waf1 by the siRNA rescued NB4 cells from 5‐AzadC‐mediated growth inhibition. Taken together, combination of 5‐AzadC and the MEK inhibitor may be useful for treatment of individuals with a subset of AML. © 2009 UICC 相似文献
17.
Targeting MUC1 and JNK by RNA interference and inhibitor inhibit the development of hepatocellular carcinoma
下载免费PDF全文
![点击此处可从《Cancer science》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Juan Wang Wei‐hua Ni Ke‐bang Hu Xiao‐yu Zhai Fei Xie Jing Jie Nan‐nan Zhang Li‐na Jiang Hong‐yan Yuan Gui‐xiang Tai 《Cancer science》2017,108(3):504-511
Mucin 1 (MUC1), as an oncogene, is overexpressed in hepatocellular carcinoma (HCC) cells and promotes the progression and tumorigenesis of HCC through JNK/TGF‐β signaling pathway. In the present study, RNA interference (RNAi) and JNK inhibitor SP600125, which target MUC1 and/or JNK, were used to treat HCC cells in vitro, and the results showed that both silencing the expression of MUC1 and blocking the activity of JNK inhibited the proliferation of HCC cells. In addition, MUC1‐stable‐knockdown and SP600125 significantly inhibited the growth of tumors in the subcutaneous transplant tumor models that established in BALB/c nude mice rather than MUC1 or JNK siRNAs transiently transfection. Furthermore, the results from immunohistochemical staining assays showed that the inhibitory effects of MUC1 gene silencing and SP600125 on the proliferation of HCC cells in vivo were through the JNK/TGF‐β signaling pathway. These results indicate that MUC1 and JNK are attractive targets for HCC therapy and may provide new therapeutic strategies for the treatment of HCC. 相似文献
18.
Nazanin Mostafaie Enikö Kállay Elisabeth Sauerzapf Elisabeth Bonner Stefan Kriwanek Heide S. Cross Klaus Roland Huber Walter Krugluger 《Molecular carcinogenesis》2009,48(7):642-647
There is a growing body of evidence that disturbed circadian clock gene expression is associated with tumor development and tumor progression. Based on our initial experiments demonstrating decreased period 1 (Per1) expression in colon cancer, we evaluated clock gene and estrogen receptor (ER) alpha/beta expression in colon cancer cells of primary colorectal tumors and adjacent normal colon mucosa (NM) by real‐time RT‐PCR. Analysis of gene expression in G2 and G3 colorectal tumors revealed a decrease of Per1 mRNA compared with paired NM (G2: 0.52‐fold; P = n.s. and G3: 0.48‐fold; P = 0.03). A significant gender specific difference of Per1 expression was observed in G2 tumors as compared with NM (female: 0.38‐fold; P = 0.004 vs. male: 0.73‐fold; P = n.s.). Expression of CLOCK was significantly elevated in G2 tumors of male patients (1.63‐fold, P = 0.01). The expression of ER‐beta was significantly decreased in G2 and G3 tumors (G2: 0.32‐fold; P = 0.003 and 0.27; P = 0.001). No significant gender specific differences of ER‐beta reduction in tumors were observed. A significant correlation between the decrease of Per1 and ER‐beta in colorectal tumors (r = 0.61; P < 0.001) was found. No changes in gene expression were detected for ER‐alpha and Per2. Our data demonstrate a correlated decrease of Per1 and ER‐beta in colorectal tumors, mediated probably by epigenetic mechanisms. The observed gender differences in the expression of CLOCK and Per1 in G2 tumors might suggest a gender‐specific, distinctive role of the cellular clock in colorectal tumorigenesis. © 2009 Wiley‐Liss, Inc. 相似文献
19.
Serum interleukin‐6 associated with hepatocellular carcinoma risk: A nested case–control study
下载免费PDF全文
![点击此处可从《International journal of cancer. Journal international du cancer》网站下载免费的PDF全文](/ch/ext_images/free.gif)
John B. Cologne Saeko Fujiwara Gen Suzuki Tomonori Hayashi Yasuharu Niwa Masazumi Akahoshi Keiko Ueda Masataka Tsuge Kazuaki Chayama 《International journal of cancer. Journal international du cancer》2014,134(1):154-163
Inflammatory markers have been associated with increased risk of several cancers, including colon, lung, breast and liver, but the evidence is inconsistent. We conducted a nested case–control study in the longitudinal cohort of atomic‐bomb survivors. The study included 224 hepatocellular carcinoma (HCC) cases and 644 controls individually matched to cases on gender, age, city and time and method of serum storage, and countermatched on radiation dose. We measured C‐reactive protein (CRP) and interleukin (IL)‐6 using stored sera obtained within 6 years before HCC diagnosis from 188 HCC cases and 605 controls with adequate volumes of donated blood. Analyses with adjustment for hepatitis virus infection, alcohol consumption, smoking habit, body mass index (BMI) and radiation dose showed that relative risk (RR) of HCC [95% confidence interval (CI)] in the highest tertile of CRP levels was 1.94 (0.72–5.51) compared to the lowest tertile (p = 0.20). RR of HCC (95% CI) in the highest tertile of IL‐6 levels was 5.12 (1.54–20.1) compared to the lowest tertile (p = 0.007). Among subjects with BMI > 25.0 kg/m2, a stronger association was found between a 1‐standard deviation (SD) increase in log IL‐6 and HCC risk compared to subjects in the middle quintile of BMI (21.3–22.9 kg/m2), resulting in adjusted RR (95% CI) of 3.09 (1.78–5.81; p = 0.015). The results indicate that higher serum levels of IL‐6 are associated with increased HCC risk, independently of hepatitis virus infection, lifestyle‐related factors and radiation exposure. The association is especially pronounced among subjects with obesity. 相似文献